UBS raised the firm’s price target on Accenture (ACN) to $395 from $390 and keeps a Buy rating on the shares. “Mangeable” DOGE for fiscal 2026 supports the stock, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACN:
- Accenture, SAP expand partnership to launch Advance
- Accenture to acquire Yumemi, terms undisclosed
- Accenture acquires Ascendient Learning, terms not disclosed
- Here’s what Wall Street is saying about IBM ahead of earnings
- Trump Trade: Trump considers cutting tariffs on Chinese imports